Yam breeding at IITA: achievements, challenges, and prospects

African food system Yam (Dioscorea spp.) is a multispecies, clonally propagated crop cultivated for its starchy tubers. About 10 species are widely cultivated around the world, but only D. rotundata, D. alata, and D. cayenensis are the most widely cultivated species in West Africa, accounting for 93% of the global yam production. Since inception, IITA R4D efforts have focused on developing new varieties of yam with desired agronomic and quality traits and to improve yam-based cropping systems

Improvement of accession distinctiveness as an added value to the global worth of the yam (Dioscorea spp) genebank

Open Access JournalMisidentification of accessions is a common problem in genebanks. Along the years, mistakes accumulate and this is particularly true when dealing with a large number of accessions requiring annual regeneration. Human errors such as mislabeling or misreading and material mix up during planting or storage are the main causes for misidentification of accessions. The international collection of yam, maintained at IITA, has accumulated ‘non true to type’ accessions along the years. In the present study, 53 morphological descriptors were used to detect uniformity of individuals within accessions of the yam gene bank collection i.e. agro morphological mismatch between individual plants of the same accession. Based on a similarity matrix, individual pairs with less than 0.90 similarity coefficients, which varies in six descriptors and more, were considered as distinct and mismatched, whereas those that had similarity coefficients greater than or equal to 0.90 were considered as clones from the same parent. Overall, 20.60% of the total 3156 accessions were found not true to type i.e., misidentified individuals. The descriptive analysis shows that morphological traits like distance between lobes, upward folding of leaf along main vein, young stem color, old stem color, leaf shape, leaf density and plant vigor are the most discriminative descriptors for individual identification within accession. Some other traits were also found species specific and they may aid in distinguishing misidentifications between species

A manual for large-scale sample collection, preservation, tracking, DNA extraction, and variety identification analysis

Several alternative options have been used for varietal identification. However most of the traditional methods have inherent uncertainty levels and estimates often have wide confidence intervals. In an attempt to circumvent traditional survey-based measurement errors in varietal identification, DNA-based varietal identification has been implemented in the Cassava Monitoring Survey (CMS) of Nigeria — a large adoption study involving 2500 cassava farming households. The DNA fingerprinting technique offers a reliable method to accurately identify varieties grown by farmers and increases accuracy and credibility in the interpretation of adoption rates and associated economic and policy analyses. Unlike phenotype-based methods, DNA is not affected by environmental conditions or plant growth stage and is more abundant than morphological descriptors. However, undertaking a credible DNA-based varietal identification is not a trivial matter because of the logistical challenges involving sample collection and tracking by a large team of field enumerators. This manual presents the detailed steps required for undertaking reliable DNA-fingerprinting-based identification of cassava varieties. In particular, the manual gives detailed information on the establishment of a sample tracking system, preparation of a readily available and cheap sample collection kit, field sample collection methodology, preparation of samples for DNA isolation, and development of a pipeline for variety identification analysis. This manual is part of the outputs of the CMS project funded by the CGIAR Research Program on Roots, Tubers and Bananas (RTB), the Bill & Melinda Gates Foundation, and the International Institute of Tropical Agriculture (IITA)

Cassava farmers' preferences for varieties and seed dissemination system in Nigeria: gender and regional perspectives

The Cassava Monitoring Survey (CMS) project was funded by the CGIAR-RTB Program and the Bill & Melinda Gates Foundation. The main goal was to carry out a study on cassava adoption and diffusion patterns in Nigeria. This includes explaining why farmers are adopting certain varieties and describing preference differences across regions and gender. This specific study and report is part of Component IV of the broader CMS Project, and it covered gender-differentiated, end-user surveys on varietal and trait preferences. The objective of this component was to use qualitative methods to probe deeper into some of the information that was obtained in the quantitative survey on gender-based trait preferences and seed dissemination pathways

Simple sequence repeat-based mini-core collection for white Guinea yam (Dioscorea rotundata) germplasm

Open Access Article; Published online: 07 Dec 2020A core subset with a small number of accessions representing the genetic diversity of the base collection plays a vital role in facilitating efficient utilization of plant genetic resources. This is particularly relevant for vegetatively propagated large plant size tuber crops with a long growing period, such as white Guinea yam (Dioscorea rotundata Poir.). For the efficient utilization of D. rotundata genetic resources, this study was aimed at developing a mini‐core collection from a core collection of 447 D. rotundata accessions maintained at the International Institute of Tropical Agriculture (IITA). Accordingly, a D. rotundata mini‐core collection representing 102 accessions was selected using 16 simple sequence repeat (SSR) markers, retaining ∼98% of the SSR allelic diversity of the base collection. A similar level of diversity was captured within the mini‐core collection and the base collection with respect to 21 morphological traits, ploidy level, and geographic origin. The mini‐core collection demonstrated a wide range of variation in agronomic traits such as growth period, number of tubers, average tuber weight, and total yield per plant. This variation was considerable when compared with the variation observed for the same traits among the 10 lines or genotypes conventionally used in the breeding program at IITA, which were included in this study as checks. The selected mini‐core accessions could serve as a working collection to broaden the genetic variation for use in practical breeding programs, as well as in future genomic analyses aimed at the genetic improvement of D. rotundata in West Africa

Spatial and genetic clustering of Plasmodium falciparum and Plasmodium vivax infections in a low-transmission area of Ethiopia.

The distribution of malaria infections is heterogeneous in space and time, especially in low transmission settings. Understanding this clustering may allow identification and targeting of pockets of transmission. In Adama district, Ethiopia, Plasmodium falciparum and P. vivax malaria patients and controls were examined, together with household members and immediate neighbors. Rapid diagnostic test and quantitative PCR (qPCR) were used for the detection of infections that were genetically characterized by a panel of microsatellite loci for P. falciparum (26) and P. vivax (11), respectively. Individuals living in households of clinical P. falciparum patients were more likely to have qPCR detected P. falciparum infections (22.0%, 9/41) compared to individuals in control households (8.7%, 37/426; odds ratio, 2.9; 95% confidence interval, 1.3-6.4; P = .007). Genetically related P. falciparum, but not P. vivax infections showed strong clustering within households. Genotyping revealed a marked temporal cluster of P. falciparum infections, almost exclusively comprised of clinical cases. These findings uncover previously unappreciated transmission dynamics and support a rational approach to reactive case detection strategies for P. falciparum in Ethiopia

Serological evidence for a decline in malaria transmission following major scale-up of control efforts in a setting selected for Plasmodium vivax and Plasmodium falciparum malaria elimination in Babile district, Oromia, Ethiopia.

BACKGROUND: Following successful malaria control during the last decade, Ethiopia instituted a stepwise malaria elimination strategy in selected low-transmission areas. METHODS: Cross-sectional surveys were conducted in Babile district, Oromia, Ethiopia from July to November 2017 to evaluate malaria infection status using microscopy and nested polymerase chain reaction (nPCR) and serological markers of exposure targeting Plasmodium falciparum and Plasmodium vivax apical membrane antigen-1 (AMA-1). RESULTS: Parasite prevalence was 1.2% (14/1135) and 5.1% (58/1143) for P. falciparum and 0.4% (5/1135) and 3.6% (41/1143) for P. vivax by microscopy and nPCR, respectively. Antibody prevalence was associated with current infection by nPCR for both P. falciparum (p<0.001) and P. vivax (p=0.014) and showed an age-dependent increase (p<0.001, for both species). Seroconversion curves indicated a decline in malaria exposure 15 y prior to sampling for P. falciparum and 11.5 y prior to sampling for P. vivax, broadly following malaria incidence data from district health offices, with higher antibody titres in adults than children for both species. CONCLUSIONS: Malaria transmission declined substantially in the region with continuing heterogeneous but measurable local transmission, arguing in favour of continued and tailored control efforts to accelerate the progress towards elimination efforts

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019

Background: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic. Methods: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0). Findings: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1–38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78–0·91) per female living with HIV in 2019, 0·99 male infections (0·91–1·10) for every female infection, and 1·02 male deaths (0·95–1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58–35·43, and a 39·66% decrease in deaths, 36·49–42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05–0·06) and the global incidence-to-mortality ratio was 1·94 (1·76–2·12). No regions met suggested thresholds for progress. Interpretation: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics. Funding: The Bill & Melinda Gates Foundation, the National Institute of Mental Health of the US National Institutes of Health (NIH), and the National Institute on Aging of the NIH

Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016

The UN’s Sustainable Development Goals (SDGs) are grounded in the global ambition of “leaving no one behind”. Understanding today’s gains and gaps for the health-related SDGs is essential for decision makers as they aim to improve the health of populations. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016), we measured 37 of the 50 health-related SDG indicators over the period 1990–2016 for 188 countries, and then on the basis of these past trends, we projected indicators to 2030

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Background: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97\ub71 (95% UI 95\ub78-98\ub71) in Iceland, followed by 96\ub76 (94\ub79-97\ub79) in Norway and 96\ub71 (94\ub75-97\ub73) in the Netherlands, to values as low as 18\ub76 (13\ub71-24\ub74) in the Central African Republic, 19\ub70 (14\ub73-23\ub77) in Somalia, and 23\ub74 (20\ub72-26\ub78) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91\ub75 (89\ub71-93\ub76) in Beijing to 48\ub70 (43\ub74-53\ub72) in Tibet (a 43\ub75-point difference), while India saw a 30\ub78-point disparity, from 64\ub78 (59\ub76-68\ub78) in Goa to 34\ub70 (30\ub73-38\ub71) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4\ub78-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20\ub79-point to 17\ub70-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17\ub72-point to 20\ub74-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle- SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view-and subsequent provision-of quality health care for all populations